事件：公司近期披露24 年全年业绩预告，集团24 年收入预计实现近10%的增长，净亏损不超过275 百万美元，较上年同期亏损收窄超过58%。其中，出海业务收入同比增长约80%，得益于全球化平台的协同和集约优势。点评：国内外不利因素较多，亏损幅度如期收窄。全年销售收入同比增长近10%，其中心脉医疗（大动脉及外周血管介入业务）收入同比增长约1.6%、微创脑科学（神经介入业务）收入实现双位数增长、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.